Our data showed that knockdown of DKK1 in cancer cells successfully reduced the RSPO2- or RANKL-induced OP recruitment and osteoclast number and activity in tibiae and spines (Figure 6, A and B, and Supplemental Figure 6, G–I). The gene discussed is DKK1; the disease is cancer.